These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25999958)

  • 21. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
    Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
    Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of nitrates in the prevention of contrast-induced nephropathy in patients hospitalized after undergoing percutaneous coronary intervention.
    Peguero JG; Cornielle V; Gomez SI; Issa OM; Heimowitz TB; Santana O; Goldszer RC; Lamas GA
    J Cardiovasc Pharmacol Ther; 2014 May; 19(3):310-4. PubMed ID: 24367008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Volume-to-creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: implications of varying definitions of contrast-induced nephropathy.
    Capodanno D; Ministeri M; Cumbo S; Dalessandro V; Tamburino C
    Catheter Cardiovasc Interv; 2014 May; 83(6):907-12. PubMed ID: 23934631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Female gender and contrast-induced nephropathy in primary percutaneous intervention for ST-segment elevation myocardial infarction.
    Lucreziotti S; Centola M; Salerno-Uriarte D; Ponticelli G; Battezzati PM; Castini D; Sponzilli C; Lombardi F
    Int J Cardiol; 2014 Jun; 174(1):37-42. PubMed ID: 24698233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of contrast-induced nephropathy in chronic total occlusion percutaneous coronary intervention.
    Lin YS; Fang HY; Hussein H; Fang CY; Chen YL; Hsueh SK; Cheng CI; Yang CH; Chen CJ; Hang CL; Yip HK; Wu CJ
    EuroIntervention; 2014 Feb; 9(10):1173-80. PubMed ID: 24561734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
    Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of uric acid and contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED.
    Saritemur M; Turkeli M; Kalkan K; Tanboga İH; Aksakal E
    Am J Emerg Med; 2014 Feb; 32(2):119-23. PubMed ID: 24238488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical impact of nephropathy induced by contrast medium in patients with acute myocardial infarction undergoing emergent coronary angiography].
    Jujo K; Yamaguchi J; Obayashi K; Suzuki K; Sekiguchi H; Nagashima M; Tsurumi Y; Kasanuki H
    J Cardiol; 2006 Jul; 48(1):9-16. PubMed ID: 16886495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention.
    Iakovou I; Dangas G; Mehran R; Lansky AJ; Ashby DT; Fahy M; Mintz GS; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
    J Invasive Cardiol; 2003 Jan; 15(1):18-22. PubMed ID: 12499523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of anisodamine on prevention of contrast induced nephropathy in patients with acute coronary syndrome.
    Wang YB; Fu XH; Gu XS; Wang XC; Zhao YJ; Hao GZ; Jiang YF; Fan WZ; Wu WL; Li SQ; Xue L
    Chin Med J (Engl); 2012 Mar; 125(6):1063-7. PubMed ID: 22613532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between Serum Ferritin and Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Zhu B; Hou J; Gong Y; Yan G; Wang Q; Wang D; Qiao Y; Chen Y; Tang C
    Biomed Res Int; 2016; 2016():5420345. PubMed ID: 27547760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of High Dose Rosuvastatin Loading before Percutaneous Coronary Intervention on Contrast-Induced Nephropathy.
    Yun KH; Lim JH; Hwang KB; Woo SH; Jeong JW; Kim YC; Joe DY; Ko JS; Rhee SJ; Lee EM; Oh SK
    Korean Circ J; 2014 Sep; 44(5):301-6. PubMed ID: 25278982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Association between high-sensitivity C-reactive protein and contrast-induced nephropathy after primary percutaneous coronary intervention].
    He YT; Tan N; Liu YH; Chen SQ; Liu Y; Huang SJ; Yang DH; Ye P; Ran P
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 May; 41(5):394-8. PubMed ID: 24021122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the Relationship Between Inflammatory Markers and Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome After Coronary Angiography.
    Zorlu C; Koseoglu C
    Angiology; 2020 Mar; 71(3):249-255. PubMed ID: 31808357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Contrast induced nephropathy in acute coronary syndrome].
    Carnevalini M; Giorgi M; Waldman S; Caturla N; Ovejero R; Falconi E; San Miguel L; Caroli C; Magariños E; Cohen Arazi H
    Medicina (B Aires); 2011; 71(5):441-8. PubMed ID: 22057170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.
    Wang XC; Fu XH; Wang YB; Jia XW; Wu WL; Gu XS; Zhang J; Su JL; Hao GZ; Jiang YF; Fan WZ; Li SQ
    Chin Med J (Engl); 2011 Mar; 124(6):892-6. PubMed ID: 21518598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention.
    Tan N; Liu Y; Zhou YL; He PC; Yang JQ; Luo JF; Chen JY
    Catheter Cardiovasc Interv; 2012 Jan; 79(1):70-5. PubMed ID: 21990069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.
    Oksuz F; Yarlioglues M; Cay S; Celik IE; Mendi MA; Kurtul A; Cankurt T; Kuyumcu S; Canpolat U; Turak O
    Am J Cardiol; 2015 Sep; 116(5):711-6. PubMed ID: 26116992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention.
    Maioli M; Toso A; Gallopin M; Leoncini M; Tedeschi D; Micheletti C; Bellandi F
    J Cardiovasc Med (Hagerstown); 2010 Jun; 11(6):444-9. PubMed ID: 20164783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention.
    Liu Y; Tan N; Zhou YL; Chen YY; Chen JY; Chen J; Luo JF
    J Nephrol; 2012; 25(3):332-40. PubMed ID: 21928234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.